Evolent Health (EVH) said Tuesday that Rick Jelinek has been named the company's new board chairman, effective at the company's next annual meeting.
The specialty health care company said Jelinek will succeed Cheryl Scott as chair.
Jelinek, who is managing partner at Czech One Capital Partners and previously was an executive vice president at CVS Health (CVS), joined the Evolent board in 2023.
Evolent also said health care investor Brendan Springstubb will join the board as an independent director when Scott steps down after three years on the panel.
The company also said its board plans to select another independent member, with directors on its nominating and governance committee now evaluating potential director nominees.
Price: 10.26, Change: +0.04, Percent Change: +0.44
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。